Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 270-877-4 | CAS number: 68479-98-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- The experimental phases of the study were performed between July 17, 2000 and August 10, 2000.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- This study was performed in accordance with Good Laboratory Practice standards. The study followed the UKEMS Subcommittee on Guidelines for Mutagenicity Testing, Report, Part 1 revised (Basic Mutagenicity Tests: UKEMS recommended procedures, 1990). The study design also complied with the revised OECD Guidelines for Testing of Chemicals Number 474 Micronucleus Test and Method B.12 of the EEC Commission Directive 92/69/EEC.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Basic Mutagenicity Tests: UKEMS recommended procedures, 1990
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Diethylmethylbenzenediamine
- EC Number:
- 270-877-4
- EC Name:
- Diethylmethylbenzenediamine
- Cas Number:
- 68479-98-1
- Molecular formula:
- C11H18N2
- IUPAC Name:
- diethylmethylbenzenediamine
- Details on test material:
- - Name of test material (as cited in study report): LZ1224.20; Diethyltoluenediamine; DETDA 80
- Physical state: Amber slightly viscous liquid
- Analytical purity: 98.4%
- Impurities (identity and concentrations): 0.4% ethyl toluenediamine (GC); <0.0150% toluenediamine (GC); 0.02% (w/w) water (KF)
- Composition of test material, percentage of components: 77.6% 3,5-diethyltoluene-2,4-diamine (GC); 20.8% 3,5-diethyltoluene-2,6-diamine (GC)
- Purity test date: August 31, 2000
- Lot/batch No.: 2235
- Storage condition of test material: Approximately 4 degrees Celsius under nitrogen
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- ICR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Limited, Margate, Kent
- Age at study initiation: Approximately 5 to 8 weeks old
- Weight at study initiation: 25 to 30 grams
- Assigned to test groups randomly: [yes, under following basis: animals were selected at random and given a number unique within the study by ear punching and a number on a color coded cage card]
- Fasting period before study:
- Housing: Groups of up to 7 in solid-floor polypylene cages with woodflake bedding
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25 °C
- Humidity (%): 30 to 70%
- Air changes (per hr): 15 changes per hour
- Photoperiod (hrs dark / hrs light): 12 hrs dark / 12 hrs light
IN-LIFE DATES: From: July 5, 2000 To: July 7, 2000
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: arachis oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: The test material was freshly prepared as required as a solution at the appropriate concentration in arachis oil.
- Duration of treatment / exposure:
- All animals were dosed once only at the appropriate dose level by gavage.
- Post exposure period:
- Animals were observed for signs of overt toxicity and death one hour after dosing and then once daily as applicable. For the preliminary range-finding study, animals were sacrificed at 48 hours following dosing. For the micronucleus study, animals were sacrificed at 24 or 48 hours post dosing.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
Basis:
nominal conc.
12.5 mg/ml (125 mg/kg bw)
- Remarks:
- Doses / Concentrations:
Basis:
nominal conc.
25 mg/ml (250 mg/kg bw)
- Remarks:
- Doses / Concentrations:
Basis:
nominal conc.
50 mg/ml (500 mg/kg bw)
- No. of animals per sex per dose:
- 7
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Justification for choice of positive control(s): Shown to produce micronuclei under the conditions of the test
- Route of administration: oral gavage
- Doses / concentrations: 50 mg/kg; 5 mg/ml
Examinations
- Tissues and cell types examined:
- Polychromatic and normochromatic erythrocytes were examined.
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: The doses selected for the micronucleus study were based on the results from a range-finding toxicity study in which 2 male and 2 female mice were administered the test material at dose levels of 300 mg/kg, 450 mg/kg, or 600 mg/kg by oral gavage.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
Groups of mice (n=7/group) were dosed once only via the oral route with the test material at 125 mg/kg, 250 mg/kg, or 500 mg/kg. One group of mice from each dose level was killed by cervical dislocation 24 hours following treatment and a second group dosed at 500 mg/kg at 48 hours. In addition, three further groups of mice were included in the study; two groups (n=7/group) were dosed via the oral route with the vehicle alone (arachis oil) and a third group (n=5) was dosed orally with the positive control material. The vehicle controls were killed 24 or 48 hours following dosing and positive control group animals were killed 24 hours following dosing.
DETAILS OF SLIDE PREPARATION:
Immediately following sacrifice (i.e., 24 or 48 hours following dosing), both femurs were dissected from each animal, aspirated with fetal calf serum and bone marrow prepared following centrifugation and resuspension. The smears were air-dried, fixed in absolute methanol and stained in May-Grunwald/Giemsa, allowed to air-dry and coverslipped using mounting medium.
METHOD OF ANALYSIS:
Stained bone marrow smears were coded and examined blind using light microscopy at x1000 magnification. The incidence of micronucleated cells per 2000 polychromatic erythrocytes (PCE-blue stained immature cells) per animal was scored. Micronuclei are normally circular in shape, although occassionally they may be oval or half-moon shaped, and have a sharp contour with even staining. In addition, the number of normochromatic erythrocytes (NCE-pink stained mature cells) associated with 1000 erythrocytes were counted; these cells were also scored for incidence of micronuclei. The ratio of polychromatic to normochromatic erythrocytes was calculated together with appropriate group mean values and standard deviations. - Evaluation criteria:
- A comparison was made between the number of micronucleated polychromatic erythrocytes occurring in each of the test material groups and the number occurring in the corresponding vehicle control group.
A positive mutagenic response was demonstrated when a statistically significant, dose-responsive, toxicologically relevant increase in the number of micronucleated polychromatic erythrocytes was observed for either the 24 or 48-hour kill times when compared to their corresponding control group.
If these criteria were not demonstrated, then the test material was considered to be non-genotoxic under the conditions of the test.
A positive response for bone marrow toxicity was demonstrated when the dose group mean polychromatic to normochromatic ratio was shwon to be statistically significantly lower than the concurrent vehicle control group. - Statistics:
- All data were statistically analyzed using appropriate statistical methods as recommended by the UKEMS Subcommittee on Guidelines for Mutagenicity Testing Report, Part III (1989). The data were analyzed following a square root of (x +1) transformation using Student's t-test (two tailed) and any significant results were confirmed using the one way analysis of variance.
Results and discussion
Test results
- Sex:
- male
- Genotoxicity:
- negative
- Remarks:
- up to the limit dose of 500 mg/kg bw
- Toxicity:
- yes
- Remarks:
- observed at 125 mg/kg bw and higher
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING TOXICITY STUDY
The dose levels for the preliminary study were 300 mg/kg bw, 450 mg/kg bw, and 600 mg/kg bw. In animals dosed with the test material via the oral route, premature death occurred at 600 mg/kg bw and clinical signs were observed at and above 300 mg/kg, as follows: lethargy, hunched posture, ptosis, decreased respiratory rate, labored respiration, ataxia, and splayed gait.
The test material showed no marked difference in its toxicity to male or female mice. Therefore, males were used for the definitive study. Adequate evidence of test material toxicity was demonstrated via the oral route of administration to warrant the same route in the main study. The maximum tolerated dose of the test material, 500 mg/kg bw, was selected for use in the main study, with 250 and 125 mg/kg bw as the lower dose levels.
MICRONUCLEUS STUDY
Mortality Data and Clinical Observations
There were no premature deaths seen in any of the dose groups. Clinical signs were observed in animals dosed with the test material at and above 125 mg/kg bw in both the 24 and 48-hour groups, where applicable, these were as follows: hunched posture, lethargy, and ptosis.
Evaluation of Bone Marrow Slides
There were no statistically significant decreases in the PCE/NCE ratio in the 24 or 48-hour test material groups when compared to their concurrent vehicle control groups. However, the presence of clinical observations indicated that systemic absorption had occurred. There were no statistically significant increases in the frequency of micronucleated PCEs in any of the test material dose groups when compared to their concurrent vehicle control groups.
The positive control group showed a marked increase in the incidence of micronucleated polychromatic erythrocytes hence confirming the sensitivity of the system to the known mutagenic activity of cyclophosphamide under the conditions of the test.
The test material was found not to produce a significant increase in the frequency of micronuclei in polychromatic erythrocytes of mice under the conditions of the test.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
The test material did not produce an increase in the frequency of micronuclei in polychromatic erythrocytes, and was therefore considered non-genotoxic under the conditions of this test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.